Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN108033922B reveals a metal-free radical acylation method for 3-acyl quinoxalinones. Achieve high purity and cost reduction in API manufacturing with this green technology.
Patent CN116640146B enables efficient one-pot synthesis. Reduces cost and improves supply chain for pharmaceutical intermediates globally.
Novel palladium-catalyzed pathway utilizes nitroarenes for efficient amide construction offering substantial cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method for 1,2,4-triazol-3-ones. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Patent CN113511986B reveals catalyst-free method. Reduces cost, improves supply chain for pharmaceutical intermediates manufacturing globally.
Patent CN119161318A reveals a novel palladium-catalyzed route for benzopyran amides offering significant supply chain stability and cost reduction advantages.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high enantioselectivity and potent anticancer activity.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and scalable manufacturing for anticancer drug development.
Novel Pd-catalyzed carbonylation patent CN114751883B offers efficient route. Reduces steps, enhances supply chain reliability for high-purity pharmaceutical intermediates.
Discover the novel 6-step preparation method for CDK4/6 inhibitor SHR6390. Enhanced yield, mild conditions, and scalable process for high-purity pharmaceutical intermediates.
Patent CN113735756A details a novel Rh-catalyzed C-H activation method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN115260188B reveals a cost-effective cobalt-catalyzed carbonylation route for tetrahydro-beta-carbolinones, offering significant supply chain and purity advantages for pharmaceutical manufacturing.
Novel Pd-catalyzed carbonylation patent CN115286628B enables efficient synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN107216307A details a mild copper-catalyzed benzylic C-H arylation method, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN120247882B reveals mild synthesis for antitumor compounds. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Novel boric porphyrin catalyzed route for avanafil offers high purity and green manufacturing advantages for reliable API intermediate suppliers.
Patent CN114276244B reveals mild synthesis for carboxylic acids. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Novel patent CN118126005B details metal-free synthesis of fluorinated heterocycles. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113666862A details a novel nickel-catalyzed asymmetric nitration for chiral 3-nitroindoles, offering superior stereoselectivity and cost efficiency for pharmaceutical intermediates.
Patent CN114133389B details a one-pot synthesis of isoindolin-1-one fused rings, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.